A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7.

Quénet, François; Élias, Dominique; Roca, Lise; Goèré, Diane; Ghouti, Laurent; Pocard, Marc; Facy, Olivier; Arvieux, C.; Lorimier, G.; Pezet, Denis; Marchal, Frédéric; Loi, Valeria; Méeus, Pierre; de Forges, Hélène; Stanbury, Trevor; Paineau, J; Gléhen, Olivier; Group and the French BIG-Renape Group, UNICANCER-GI

doi:10.1200/jco.2018.36.18_suppl.lba3503

Public

A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7.

Published in Journal of Clinical Oncology • Jun 7, 2018

Authors:

François Quénet

Dominique Élias

Lise Roca

Abstract

LBA3503 Background: Promising results have been obtained during the last decade using cytoreductive surgery (CRS) plus HIPEC for selected patients with colorectal PC who are amenable to complete macroscopic resection. This is the first trial to evaluate the specific role of HIPEC, after CRS, for the...

Subject

Medicine

Hyperthermic intraperitoneal chemotherapy

Oxaliplatin

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!